Sinsin Pharmaceutical Co. Ltd (002800) — Cash Flow Reinvestment Rate
Sinsin Pharmaceutical Co. Ltd (002800) has a Cash Flow Reinvestment Rate of 0.21x as of September 2025, reinvesting ₩972.34 Million (capex ₩871.54 Million plus investments ₩-100.80 Million) from operating cash flow of ₩4.70 Billion. Explore Sinsin Pharmaceutical Co. Ltd capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Sinsin Pharmaceutical Co. Ltd Cash Flow Reinvestment Rate (2015–2024)
Historical reinvestment intensity for Sinsin Pharmaceutical Co. Ltd across 9 annual periods. Also explore balance sheet size of Sinsin Pharmaceutical Co. Ltd for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Sinsin Pharmaceutical Co. Ltd (2015–2024)
Year-by-year capital reinvestment analysis for Sinsin Pharmaceutical Co. Ltd. For live market cap and broader valuation context, see Sinsin Pharmaceutical Co. Ltd (002800) total market value.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.19x | ₩7.07 Billion | ₩5.94 Billion | ₩1.51 Billion | ▼ -57.8% |
| 2023 | 2.82x | ₩11.08 Billion | ₩3.93 Billion | ₩5.03 Billion | ▲ +1320.4% |
| 2022 | 0.20x | ₩1.08 Billion | ₩5.46 Billion | ₩907.13 Million | ▼ -99.8% |
| 2021 | 115.84x | ₩2.69 Billion | ₩23.18 Million | ₩2.68 Billion | ▲ +1363.9% |
| 2020 | 7.91x | ₩14.76 Billion | ₩1.87 Billion | ₩11.97 Billion | ▼ -75.9% |
| 2018 | 32.86x | ₩25.44 Billion | ₩774.24 Million | ₩25.44 Billion | ▲ +4099.6% |
| 2017 | 0.78x | ₩3.57 Billion | ₩4.57 Billion | ₩3.57 Billion | ▼ -70.8% |
| 2016 | 2.68x | ₩7.48 Billion | ₩2.79 Billion | ₩7.43 Billion | ▲ +168.4% |
| 2015 | 1.00x | ₩5.22 Billion | ₩5.24 Billion | ₩5.22 Billion | — |